PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 1, 1995Circulation Research105 citations

Effects of Doxorubicin on Excitation-Contraction Coupling in Guinea Pig Ventricular Myocardium

View Full Paper
YWYong-Xiao WangMay InstituteMKMichael KorthEuropean Molecular Biology Organization

Key Result

In guinea pig ventricular myocardium, 100 µmol/L doxorubicin increased the force of contraction by 269.3% and prolonged action potential duration by 62.1% in single myocytes.

Key Points

  • This study investigates how doxorubicin affects excitation-contraction coupling in guinea pig hearts.
  • Guinea pig papillary muscles and single myocytes were exposed to doxorubicin at 100 mumol/L for 3 hours.
  • The effects on contraction force, action potential duration, and calcium transients were measured.
  • Results were assessed using statistical analysis with samples sizes noted.
  • Doxorubicin increased contraction force by 269.3% (n=6) and prolonged relaxation time by 54.7% (n=6).
  • It prolonged action potential duration at 90% repolarization by 62.1% (n=18) in single myocytes.
  • Calcium transients were suppressed initially, followed by a delayed rise in intracellular calcium, surpassing control levels by 52% (n=5).

Structured PICO

P
Population
Guinea pig heart preparations (papillary muscles and single myocytes) used to investigate the effects of doxorubicin on excitation-contraction coupling.
I
Intervention
Doxorubicin 100 mumol/L
C
Comparator
Control (baseline/untreated preparations)
O
Outcome
Excitation-contraction coupling parameters (force of contraction, action potential duration, ion currents, and intracellular Ca2+ transients)surrogate

Doxorubicin alters excitation-contraction coupling in guinea pig ventricular myocardium by decreasing Ca2+-induced Ca2+ release from the SR and prolonging action potential duration via IK inhibition, leading to intracellular Ca2+ accumulation.

Abstract

Doxorubicin, an anticancer drug, was recently shown to release Ca2+ from cardiac sarcoplasmic reticulum (SR) by increasing the open probability of Ca2+ release channels. In the present study, we investigated the effects of doxorubicin on excitation-contraction coupling of guinea pig heart preparations. In papillary muscles contracting at 0.5 Hz, 100 mumol/L doxorubicin produced within 3 hours the following effects: it increased the force of contraction by 269.3 +/- 19.8% (n = 6) and prolonged the time to peak force by 75.1 +/- 8.7% (n = 6), relaxation time by 54.7 +/- 8.7% (n = 6), and action potential duration (APD) at 90% repolarization (APD90) by 38.6 +/- 2.9% (n = 3). Despite its positive inotropic effect, doxorubicin depressed the early contraction component by increasing the latency between stimulus and the onset of force development. In single myocytes, 100 mumol/L doxorubicin prolonged APD90 by 62.1% (n = 18) and blocked time-dependent delayed rectifier K+ current (IK) by 44% (n = 9). Ca2+ inward current and inward rectifier K+ current were not affected by doxorubicin. Ca2+ transients elicited in myocytes loaded with the fluorescent Ca2+ indicator fura 2 were strongly suppressed by doxorubicin in their initial rising phase. There-after, doxorubicin produced a delayed rise in intracellular Ca2+, which reached a late peak exceeding that of the control peak by 52 +/- 8% (n = 5). The results suggest that doxorubicin decreases Ca(2+)-induced Ca2+ release from cardiac SR, probably by increasing the SR Ca2+ leak. On the other hand, prolongation of APD due to inhibition of IK allows more Ca2+ to enter the cell. After being only temporarily buffered by the SR, Ca2+ may accumulate in the cytosol as long as depolarization is maintained and lead to a more complete activation of contractile proteins.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Wang et al. (1995) studied this question. Doxorubicin vs. Control was evaluated on Force of contraction, action potential duration, and Ca2+ transients. In guinea pig ventricular myocardium, 100 µmol/L doxorubicin increased the force of contraction by 269.3% and prolonged action potential duration by 62.1% in single myocytes.

synapsesocial.com/papers/6a225a6e9b962528977c975ahttps://doi.org/10.1161/01.res.76.4.645
Ask AI
Helpful
Bookmark
Share
View Full Paper